The PGIM Quant Solutions Small-Cap Value Fund underperformed its benchmark, the Russell 2000 Value Index, during Q1 of 2025. Click here to read the full commentary.

In a world shaped by biotechnology, why are so few college students exposed to its possibilities early on in their education?

Drug-induced liver injury (DILI) is a frequent cause of acute liver failure and drug withdrawals. Liver organoids, as a ...

Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...

Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for ...

Molecular Devices, LLC., a leading high-performance life science solutions provider, today launched the QPix® FLEX™ Microbial Colony Picking System. Building on the company's 20-year legacy developing ...